Patent · US Active

Substituted adamantanes and their therapeutic application

US8530657B2 · kind B2 · utility

0Cited by

0References

1Claims

0Family size

Assignee

Sanofi · FR

Inventors

Alain Braun · Antony, FR
Olivier Crespin · Paris, FR
Claudie Namane · Paris, FR
Eric Nicolai · Paris, FR
Francois Pacquet · Paris, FR
Cecile Pascal · Paris, FR
Christophe Philippo · Rueil-Malmaison, FR
Olivier Venier · Poitiers, FR

Key dates

Filing date	May 30, 2012
Grant date	Sep 10, 2013
Priority date	—
Expiry date	May 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to tetrahydroquinoxaline urea derivatives of formula (I)as defined herein, and, to their preparation and to their therapeutic application.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.